PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Microbiology and Virology Unit, Dermatological Clinical and Research Department, IRCCS San Gallicano Institute, Rome, Italy.\', \'Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. francesco.marchesi@ifo.gov.it.\', \'SAFU Unit, Department of Research and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy.\', \'Clinical Trial Center, Biostatistics and Bioinformatics Unit, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.\', \'Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.\', \'Biological Tissue and Liquid Bank, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.\', \'Pharmacy Unit, Medical Direction, IRCCS Regina Elena National Cancer Institute and San Gallicano Institute, Rome, Italy.\', \'Medical Direction, IRCCS Regina Elena National Cancer Institute and San Gallicano Institute, Rome, Italy.\', \'Scientific Direction, IRCCS San Gallicano Institute, Rome, Italy.\', \'Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13045-021-01130-1
?:hasPublicationType
?:journal
  • Journal of hematology & oncology
is ?:pmid of
?:pmid
?:pmid
  • 34325728
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all